Skip to main content

Vaccine safety

Vaccines used in Australia have to pass strict testing and approval processes.

On this page

Free and voluntary

COVID-19 vaccines are free for everyone in Australia regardless of Medicare or visa status.

Vaccination is voluntary – getting vaccinated is your choice.

For the type of COVID-19 vaccine expected to be used in Australia, you will need to receive 2 doses of the vaccine to be adequately immunised.

This means it will take time for every person to be vaccinated.

Until then, it is important for you to follow the rules and safe behaviour that helps keep COVID-19 from spreading.

Therapeutic Goods Administration

The Therapeutic Goods Administration (TGA) is the Australian Government's regulator for therapeutic goods such as medicines and vaccines.

The TGA makes sure that these items are safe and effective for use in Australia.

The TGA is responsible for approving vaccines, including COVID-19 vaccines.

Approved COVID-19 vaccines

Any COVID-19 vaccines approved for use in Australia are safe and effective. Before vaccines are made available, they must be approved for use in Australia. There are strict requirements for testing and approving vaccines. This includes the TGA’s thorough assessment and approval processes for safety, quality and effectiveness.

Before a vaccine is approved, it is tested. Testing begins with laboratory research, then animal studies and finally human clinical trials.

Clinical trials must provide scientific evidence which demonstrates that the benefits of a vaccine greatly outweigh any risks.

Learn more about vaccines available in Australia.

Vaccine use for vulnerable people

The Australian Government Department of Health has published a guide for women who are pregnant, breastfeeding or planning pregnancy.

Learn more about who can be vaccinated

Ongoing monitoring of vaccines

The TGA will continue to play an active role in the ongoing monitoring of any vaccines available in Australia, and has robust procedures in place to rapidly detect, investigate and respond to any emerging safety issues identified for COVID-19 vaccines.

 

Last updated:
Top of page